1. Freiberg MS, So-Armah K. HIV and Cardiovascular Disease: We Need a Mechanism, and We Need a Plan. J Am Heart Assoc. 2016;5(3).
2. Strijdom H, Charania S, Goswami N, De Boever P, Nawrot T, Mashele N, et al. Cardiovascular health and flow-mediated dilatation (fmd) in a south african cohort of hiv-infected participants-findings from the endoafrica study. Atherosclerosis. 2017;263:E141-E.
3. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457(7228):480-U7.
4. Kasselman LJ, Vernice NA, DeLeon J, Reiss AB. The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity. Atherosclerosis. 2018;271:203-13.
5. Vu CN, Ruiz-Esponda R, Yang E, Chang E, Gillard B, Pownall HJ, et al. Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients. Metabolism. 2013;62(7):1014-20.
6. Currier JS, Lundgren, J.D., Carr, A., Klein, D., Sabin, C.A., Sax, P.E., Schouten, J.T. Smieja, M., . Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy (vol 118, pg e29, 2008). Circulation. 2008;118(6):E108-E.
7. Hejazi N, Rajikan R, Choong CLK, Sahar S. Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional survey. Bmc Public Health. 2013;13.
8. Reiger S, Jardim TV, Abrahams-Gessel S, Crowther NJ, Wade A, Gomez-Olive FX, et al. Awareness, treatment, and control of dyslipidemia in rural South Africa: The HAALSI (Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa) study. Plos One. 2017;12(10).
9. Wongprikorn A, Sukasem C, Puangpetch A, Numthavej P, Thakkinstian A, Kiertiburanakul S. Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study. Plos One. 2016;11(6).
10. Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. Hiv Medicine. 2012;13(8):453-68.
11. Caron-Debarle M, Lagathu C, Boccara F, Vigouroux C, Capeau J. HIV-associated lipodystrophy: from fat injury to premature aging. Trends in Molecular Medicine. 2010;16(5):218-29.
12. Monaco CL, Gootenberg DB, Zhao GY, Handley SA, Ghebremichael MS, Lim ES, et al. Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome. Cell Host & Microbe. 2016;19(3):311-22.
13. Domingo P, Estrada V, Lopez-Aldeguer J, Villaroya F, Martinez E. Fat Redistribution Syndromes Associated with HIV-1 Infection and Combination Anti retroviral Therapy. Aids Reviews. 2012;14(2):112-23.
14. Organisation WH. Adult HIV prevalence (15-49 years). World Health Organisation; 2013 2013.
15. Murray CJ, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):1005-70.
16. Alonso A, Barnes AE, Guest JL, Shah A, Shao IY, Marconi V. HIV infection and incidence of cardiovascular diseases: an analysis of a large healthcare database. J Am Heart Assoc. 2019;8(14):e012241.
17. Fourie CM, Roux B-L, Smith W, Schutte AE, Breet Y, Mels C, et al. Vascular function and cardiovascular risk in a HIV infected and HIV free cohort of African ancestry: baseline profile, rationale and methods of the longitudinal EndoAfrica-NWU study. BMC Infectious Diseases. 2020;20(1):1-13.
18. Musarurwa HT, Sewani-Rusike CR, Nkeh-Chungag BN, Goswami N. Antiretroviral Drugs and the Human Gut Microbiome: Implications for the development of cardiovascular diseases in people living with HIV - An Austrian/South African Project. Acta Physiologica. 2019;227:42-.
19. National Center for Health Statistics (U.S.). National Health and Nutrition Examination Survey. California and Los Angeles County, estimation methods and analytic considerations : 1999-2006 and 2007-2014. Hyattsville, Maryland: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2017. p. p.
20. Everson FP. HIV/AIDS and air pollution as emerging cardiovascular risk factors in Cape Town populations: is endothelial function a marker of effect: Stellenbosch: Stellenbosch University; 2020.
21. Marincowitz C, Webster I, Westcott C, Strijdom H, Goswami N, De Boever P, et al. Vascular health assessment with flow-mediated dilatation and retinal image analysis: a pilot study in an adult population from Cape Town. Cardiovascular Journal of Africa. 2021;32(3):133-40.
22. Hosák L, Zeman T, Studnička J, Stepanov A, Ustohal L, Michalec M, et al. Retinal arteriolar and venular diameters are widened in patients with schizophrenia. Psychiatry Clin Neurosci. 2020;74:619-21.
23. Makhalanyane TP, Valverde A, Lacap DC, Pointing SB, Tuffin MI, Cowan DA. Evidence of species recruitment and development of hot desert hypolithic communities. Environmental Microbiology Reports. 2013;5(2):219-24.
24. Bokulich NA, Kaehler BD, Rideout JR, Dillon M, Bolyen E, Knight R, et al. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2 ' s q2-feature-classifier plugin. Microbiome. 2018;6.
25. Pavelić K, Kraljević Pavelić S, Brix B, Goswami N. A Perspective on COVID-19 Management. Journal of Clinical Medicine. 2021;10(8):1586.